These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30231854)

  • 1. Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.
    Ng SP; Bahig H; Wang J; Cardenas CE; Lucci A; Hall CS; Meas S; Sarli VN; Yuan Y; Urbauer DL; Ding Y; Ikner S; Dinh V; Elgohari BA; Johnson JM; Skinner HD; Gunn GB; Garden AS; Phan J; Rosenthal DI; Morrison WH; Frank SJ; Hutcheson KA; Mohamed ASR; Lai SY; Ferrarotto R; MacManus MP; Fuller CD
    BMC Cancer; 2018 Sep; 18(1):903. PubMed ID: 30231854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.
    Rumley CN; Lee MT; Holloway L; Rai R; Min M; Forstner D; Fowler A; Liney G
    BMC Cancer; 2017 Jul; 17(1):475. PubMed ID: 28693449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Circulating Tumor Cell Measurements with 3D Quantitative Tumor Characterization to Predict Clinical Outcomes in Cancer.
    Ng SP; Fuller CD; Skinner HD
    Methods Mol Biol; 2021; 2174():135-141. PubMed ID: 32813248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of circulating tumour cells to predict response to treatment in head and neck cancer.
    Zhang X; Ekanayake Weeramange C; Hughes BGM; Vasani S; Liu ZY; Warkiani ME; Hartel G; Ladwa R; Thiery JP; Kenny L; Punyadeera C
    Cell Oncol (Dordr); 2022 Aug; 45(4):543-555. PubMed ID: 35737211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
    Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role and responsibility of multimodal imaging in head and neck cancer].
    Gõdény M
    Magy Onkol; 2013 Sep; 57(3):182-202. PubMed ID: 24107825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
    Gupta T; Chatterjee A; Rangarajan V; Purandare N; Arya S; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal JP
    Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):162-170. PubMed ID: 31496204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
    Muhanna N; Eu D; Chan HHL; Douglas C; Townson JL; Di Grappa MA; Mohamadi RM; Kelley SO; Bratman SV; Irish JC
    BMC Cancer; 2021 Oct; 21(1):1075. PubMed ID: 34600526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning.
    Leibfarth S; Mönnich D; Welz S; Siegel C; Schwenzer N; Schmidt H; Zips D; Thorwarth D
    Acta Oncol; 2013 Oct; 52(7):1353-9. PubMed ID: 23879651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas.
    Quon H; Brizel DM
    Semin Radiat Oncol; 2012 Jul; 22(3):220-32. PubMed ID: 22687947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New opportunities, MRI biomarkers in the evaluation of head and neck cancer].
    Gődény M; Léránt G
    Magy Onkol; 2014 Dec; 58(4):269-80. PubMed ID: 25517445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
    Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multimodality segmentation framework for automatic target delineation in head and neck radiotherapy.
    Yang J; Beadle BM; Garden AS; Schwartz DL; Aristophanous M
    Med Phys; 2015 Sep; 42(9):5310-20. PubMed ID: 26328980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.
    Deleporte A; Paesmans M; Garcia C; Vandeputte C; Lemort M; Engelholm JL; Hoerner F; Aftimos P; Awada A; Charette N; Machiels G; Piccart M; Flamen P; Hendlisz A
    BMC Cancer; 2014 May; 14():385. PubMed ID: 24885112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
    Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
    BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional imaging for radiation treatment planning, response assessment, and adaptive therapy in head and neck cancer.
    Bhatnagar P; Subesinghe M; Patel C; Prestwich R; Scarsbrook AF
    Radiographics; 2013; 33(7):1909-29. PubMed ID: 24224586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.